ResMed currently trades at $218.94 per share and has shown little upside over the past six months, posting a small loss of ...

Stryker's sales have grown about 10% a year on average over the past three years, and so have ResMed's. That shared growth rate in medical devices is the bet the two have in common. Stryker (SYK) is ...

A deep-dive comparison of ResMed and Fisher & Paykel Healthcare shares: dividends, valuation, recent momentum, and which I ...

I look at what the next few years of earnings growth could mean for today’s valuation. The post Is the ResMed share price a ...

The latest announcement is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ).

An announcement from Resmed ( ) is now available. On August 31, 2026, ResMed Inc. entered into an accelerated share repurchase agreement with Citibank to buy back $450 million of ...

Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock ...

ResMed Inc. stock closed at USD 225.35 on Nasdaq on September 18, 2026, about 6.7 percent below the USD 241.69 consensus target. A September 15, 2026 upgrade to Outperform with a raised USD 262 price ...

ResMed (RMD) stock gains as RBC Capital Markets upgrades the company to Outperform and hikes target to $262, citing positives in its Q4 FY26 results. Read more here.

ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices like Apple ...

ResMed noted in a letter that of the “tens of millions” of magnet-equipped masks that it’s sold around the world between 2014 and now, it has only received five reports of serious harm potentially ...

SAN DIEGO, Calif., Feb. 22, 2016 /PRNewswire/ -- ResMed (NYSE:RMD), the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today ...